Management of pregnant women with breast cancer

Journal of Surgical Oncology

Volumn 103, Issue 4, 2011, Pages 337-340

  Guidroz, Julie A ^a   Scott Conner, Carol E H ^a   Weigel, Ronald J ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Breast cancer; Diagnosis; Pregnancy; Treatment

Indexed keywords

TRASTUZUMAB;

BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; DELIVERY; FAMILIAL CANCER; GENETIC SCREENING; HIGH RISK PREGNANCY; HUMAN; LYMPHOSCINTIGRAPHY; MASTECTOMY; PARTIAL MASTECTOMY; PREGNANCY TERMINATION; PREGNANT WOMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SECOND TRIMESTER PREGNANCY; SENTINEL LYMPH NODE BIOPSY; THIRD TRIMESTER PREGNANCY;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; FEMALE; HUMANS; MASTECTOMY; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC;

EID: 79952018822     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21673     Document Type: Review

References (26)

1. Ring A, Smith I, Jones A, et al.: Chemotherapy for breast cancer during pregnancy: An 18-year experience from five London teaching hospitals. J Clin Oncol 2005;23:4192-4197. (Pubitemid 46211325)
2. Navrozoglou I, Vrekoussis T, Kontostolis E, et al.: Breast cancer during pregnancy: A mini-review. Eur J Surg Oncol 2008;34: 837-843.
3. Reed W, Sandstad B, Holm R, et al.: The prognostic impact of hormone receptors and c-erbB-2 in pregnancy-associated breast cancer and their correlation with BRCA1 and cell cycle modulators. Int J Surg Pathol 2003;11:65-74. (Pubitemid 36569927)
4. Lyons T, Schedin P, Borges V: Pregnancy and breast cancer: When they collide. J Mammary Gland Biol Neoplasia 2009;14: 87-98.
5. Jones A: Management of pregnancy-associated breast cancer. Breast 2006;15:S47-S52.
6. Berry DL, Theriault RL, Holmes FA, et al.: Management of breast cancer during pregnancy using a standardized protocol. J Clin Oncol 1999;17:855-861. (Pubitemid 29109315)
7. Scott-Conner CE, Schorr SJ: The diagnosis and management of breast problems during pregnancy and lactation. Am J Surg 1995; 170:401-405.
8. Garca-Manero M, Royo MP, Espinos J, et al.: Pregnancy associated breast cancer. Eur J Surg Oncol 2009;35:215-218.
9. Keleher A, Theriault R, Gwyn K, et al.: Multidisciplinary management of breast cancer concurrent with pregnancy. J Am Coll Surg 2002;194:54-64. (Pubitemid 34044875)
10. Pisano E, Gatsonis C, Hendrick E, et al.: Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med 2005;353:1773-1783. (Pubitemid 41549889)
11. Reed W, Hannisdal E, Skovlund E, et al.: Pregnancy and breast cancer: A population-based study. Virchows Archiv 2003;443: 44-450.
12. Ulery M, Carter L, McFarlin B, et al.: Pregnancy-associated breast cancer: Significance of early detection. J Midwifery Women's Health 2009;54:357-363.
13. Bodner-Adler B, Bodner K, Zeisler H: Breast cancer diagnosed during pregnancy. Anticancer Res 2007;27:1705-1707. (Pubitemid 46807262)
14. Molckovsky A, Madarnas Y: Breast cancer in pregnancy: A literature review. Breast Cancer Res Treat 2008;108:333-338. (Pubitemid 351431075)
15. Rodriguez A, Chew H, Cress R, et al.: Evidence of poorer survival in pregnancy-associated breast cancer. Obstet Gynecol 2008;112: 71-78.
16. Mathelin C, Annane K, Treisser A, et al.: Pregnancy and postpartum breast cancer: A prospective study. Anticancer Res 2008;28:2447-2452.
17. Spanheimer P, Graham M, Sugg S, et al.: Measurement of uterine radiation exposure from lymphoscintigraphy indicates safety of sentinel lymph node biopsy during pregnancy. Ann Surg Oncol 2009;16:1143-1147.
18. Mondi M, Cuenca R, Ollila D, et al.: Sentinel lymph node biopsy during pregnancy: Initial clinical experience. Ann Surg Oncol 2007;14:218-221. (Pubitemid 44954292)
19. Khera S, Kiluk J, Hasson D, et al.: Pregnancy-associated breast cancer patients can safely undergo lymphatic mapping. Breast J 2008;14:250-254. (Pubitemid 351678056)
20. Johnson M, Guidroz JA, Smith B, et al.: A single institutional experience of factors affecting successful identification of sentinel lymph node in breast cancer patients. Surgery 2009;146:2671-2676.
21. Hahn KME, Johnson P, Gordon N, et al.: Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer 2006;107:1219-1226. (Pubitemid 44452769)
22. American College of Obstetricians and Gynecologists. Hereditary breast and ovarian cancer syndrome. ACOG Practice Bulletin No. 103. Obstet Gynecol 2009;113:957Y966.
23. Eitan R, Michaelson-Cohen R, Levavi H, et al.: The counseling and management of young healthy BRCA mutation carriers. Int J Gynecol Cancer 2009;19:1156-1159.
24. Milne RL, Osorio A, Ramón y, et al.: Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat 2010; 119: 221-232 [Epub 2009 April 16].
25. Lee E, Ma H, McKean-Cowdin R, et al.: Effect of reproductive factors and oral contraceptives on breast cancer risk in BRCA1/2 mutation carriers and noncarriers: Results from a population based study. Cancer Epidemiol Biomarkers Prev 2008;17: 3170-3178.
26. Narod SA: Modifiers of risk of hereditary breast cancer. Oncogene 2006; 25: 5832-5836.